“Lebrikizumab Delivers Clinically Meaningful and Continuous Improvement in Itch-Free Days in Atopic Dermatitis Through One Year”. 2023. SKIN The Journal of Cutaneous Medicine 7 (6): s273. https://doi.org/10.25251/skin.7.supp.273.